Anti-inflammatory potential of some eudesmanolide and guaianolide sesquiterpenes
Abstract Ten sesquiterpene lactones isolated from Anvillea garcinii (Burm.f.) DC ethanolic extract were assessed for their anti-inflammatory potential by myeloperoxidase (MPO) activity assignment, and mice paw swelling model. 3α,4α-10β-trihydroxy-8α-acetyloxyguaian-12,6α-olide (1), epi-vulgarin (3), 9a-hydroxyparthenolide (4), garcinamine C (7), garcinamine D (8), garcinamine E (9), and 4, 9-dihydroxyguaian-10(14)-en-12-olide (10) showed explicit anti-inflammatory activity in rodent paw edema and MPO assignment. The findings of this study showed that the α-methylene γ-lactone moiety does not always guarantee an anti-inflammatory effect, but the presence of proline at the $ C_{3} $ of the lactone ring improves the binding of sesquiterpene lactones with MPO isoenzymes, resulting in a more potent inhibition..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
---|---|
Enthalten in: |
Inflammopharmacology - 32(2023), 2 vom: 14. Nov., Seite 1489-1498 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Perveen, Shagufta [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Anti-inflammatory potential |
Anmerkungen: |
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
---|
doi: |
10.1007/s10787-023-01375-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR055478832 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | SPR055478832 | ||
003 | DE-627 | ||
005 | 20240411064650.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240411s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10787-023-01375-x |2 doi | |
035 | |a (DE-627)SPR055478832 | ||
035 | |a (SPR)s10787-023-01375-x-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a PHARM |q DE-84 |2 fid | ||
084 | |a 44.38 |2 bkl | ||
100 | 1 | |a Perveen, Shagufta |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anti-inflammatory potential of some eudesmanolide and guaianolide sesquiterpenes |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
520 | |a Abstract Ten sesquiterpene lactones isolated from Anvillea garcinii (Burm.f.) DC ethanolic extract were assessed for their anti-inflammatory potential by myeloperoxidase (MPO) activity assignment, and mice paw swelling model. 3α,4α-10β-trihydroxy-8α-acetyloxyguaian-12,6α-olide (1), epi-vulgarin (3), 9a-hydroxyparthenolide (4), garcinamine C (7), garcinamine D (8), garcinamine E (9), and 4, 9-dihydroxyguaian-10(14)-en-12-olide (10) showed explicit anti-inflammatory activity in rodent paw edema and MPO assignment. The findings of this study showed that the α-methylene γ-lactone moiety does not always guarantee an anti-inflammatory effect, but the presence of proline at the $ C_{3} $ of the lactone ring improves the binding of sesquiterpene lactones with MPO isoenzymes, resulting in a more potent inhibition. | ||
650 | 4 | |a Sesquiterpene lactones |7 (dpeaa)DE-He213 | |
650 | 4 | |a Anti-inflammatory potential |7 (dpeaa)DE-He213 | |
650 | 4 | |a Structure–activity relationship |7 (dpeaa)DE-He213 | |
700 | 1 | |a Hamedi, Azadeh |e verfasserin |4 aut | |
700 | 1 | |a Pasdaran, Ardalan |e verfasserin |0 (orcid)0000-0001-6713-0756 |4 aut | |
700 | 1 | |a Heidari, Reza |e verfasserin |4 aut | |
700 | 1 | |a Azam, Muhammad Shafiq ul |e verfasserin |4 aut | |
700 | 1 | |a Tabassum, Sobia |e verfasserin |4 aut | |
700 | 1 | |a Mehmood, Rashad |e verfasserin |4 aut | |
700 | 1 | |a Peng, Jiangnan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Inflammopharmacology |d Springer International Publishing, 1991 |g 32(2023), 2 vom: 14. Nov., Seite 1489-1498 |w (DE-627)SPR013448595 |w (DE-600)2047989-X |x 1568-5608 |7 nnns |
773 | 1 | 8 | |g volume:32 |g year:2023 |g number:2 |g day:14 |g month:11 |g pages:1489-1498 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10787-023-01375-x |m X:VERLAG |x 0 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_SPRINGER | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.38 |q VZ |
951 | |a AR | ||
952 | |d 32 |j 2023 |e 2 |b 14 |c 11 |h 1489-1498 |